Fortress Biotech, Inc. - 16 May 2024 Form 3 Insider Report for Checkpoint Therapeutics, Inc. (CKPT)

Role
10%+ Owner
Signature
/s/ Lindsay A. Rosenwald, M.D. Chairman, President and Chief Executive Officer
Issuer symbol
CKPT
Transactions as of
16 May 2024
Net transactions value
$0
Form type
3
Filing time
24 May 2024, 16:05:28 UTC
Previous filing
17 Apr 2024
Next filing
28 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CKPT COMMON STOCK, PAR VALUE $0.0001 3,589,193 16 May 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CKPT CLASS A COMMON STOCK, PAR VALUE $0.0001 16 May 2024 Common Stock 700,000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of the Issuer's Class A Common Stock is convertible at any time at the option of the Reporting Person into one share of the Issuer's Common Stock and has no expiration date.